Elite Pharmaceuticals Inc (QB) (ELTP) News

Stupid, good to see you back

Congrats on playing your hand so well!

Also Henry looks like a cool aid swiller made a 500 k purchase today pass the coo aid gulp, gulp, wish I had that type of coin to invest!

Price action analysis:
So Vyvanse did not give us the pop we were expecting YET!

Investors will come back from vacation beginning of January and we will have about 6 weeks to have the PPS adjusted with more growth as we get closer to Feb 15. I have also no doubt that this will be our best quarter ever, and that we are likely to get another launch before Feb 15. We could see also a pop a few days after the teleconference like we had back in August 2024. No doubt we are on a 🚀 trajectory with more and more fuel being added every 6 weeks.

Also, the price will be for 30, 60 or 90 bottles so don't we need to take capsule production max of 57K per 8 hour shift and divide by at least 30? We'd then take this and apply it to about 50% of price we see on GoodRx for a reasonable estimate for Elite revenue after pharmacy, distributor & other costs.

That sound like fair analytics?

I'm guessing 90-day supply will be the norm, but with some 30/60 mix pushing it to about 70 days. 

Hey Henry - you pay taxes to the government. We pay profit split to Mikah. MIKAH SAVED ELITE PHARMA!!!!

Hi Kayak, NAS, The reason I had Traditional IRA is that I moved my 401K to Traditional IRA every time I moved jobs. But most recently, I also moved 401K to Roth IRA -while still being employed. Traditional IRA and 401K are very similar. The only difference is that a live 401K still accepts employer's contribution.

Luckily, I did a big shares move to Roth in 2020 when the stock price was at 4.5 cents. This will allow me to increase my retirement my budget for the next 4 years until the 2024 huge conversion vests.

This is how I was able to get a multi million shares in ROTH.

A $4.3B market won't move squat?! ROFL

Guess what? All the generic competitors are out of API. Woohoo!! Can't wait for Q4 earnings call in June with a full Q under our belt. Feb's forward looking view regarding Vyvanse production will fry any shorts.

We need HGilS to give his opinion on that one as he has direct experience with it. I have never invested in a traditional IRA. It never made financial sense to me. Traditional IRAs are pre-tax. Since I work for a company my pre-tax investments have been in the companies 401K. The conversion from backdoor Roth wasn't always available as an option and I am surprised it stuck around as long as it has. So I never thought to put money into a traditional IRA with the goal of converting it all to a Roth one day.

Frankly I think taxes at this time are lower now than they are going to be in the future. In hindsight I wish I had invested in a 401k Roth for the past decade and not the traditional 401k that let me deduct the investment from my income to lower what I paid in tax each year. I think I will pay more a higher percentage when I pull that money out even with a smaller income because the tax rates may go up a lot. Social security and medicare are running out of money and we have a huge deficit. The piper is eventually going to have to be paid. I think taxes will go up and loop holes for the wealthy (like conversion from IRA to Roth IRA) will eventually end. If we are bought out are you going to keep working and have a regular income? You can't get it out of the IRA to spend until your 59.5. If your 59.5 do you need to invest in a retirement fund at all?

Get Yer Kool aide now! What flavor do you want? We have fruit punch, Grape, orange and new lemon lime. Don't worry about Vyvanse which isn't going to move squat. Worry about the Mikah Tax and other OTC things that you may or maynot like to happen.

Yes, to simplify, we record revenue when customer receives product, not when we manufacture it.

How bout all of you Roth IRA fame take a friggin break Your all talking about what to do with all that money In case you haven’t noticed the pps is 50 cents and couldn’t hold 70 cents Why not calm down clowns

Revenue Recognition - Once more:
Revenue Recognition
The Company generates revenue from manufacturing and licensing fees and direct sales to pharmaceutical distributors for pharmacies and institutions. Manufacturing fees include the development of pain management products, manufacturing of a line of generic pharmaceutical products with approved ANDA, through the manufacture of formulations and the development of new products. Licensing fees include the commercialization of products either by license and the collection of royalties, or the expansion of licensing agreements with other pharmaceutical companies, including co-development projects, joint ventures and other collaborations.

Under ASC 606, Revenue from Contacts with Customers ("ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenues following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenues when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue.

Nature of goods and services

The following is a description of the Company’s goods and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each, as applicable:

a) Manufacturing Fees

The Company is equipped to manufacture controlled-release products on a contract basis for third parties, if, and when, the products are approved. These products include products using controlled-release drug technology. The Company also develops and markets (either on its own or by license to other companies) generic and proprietary controlled-release pharmaceutical products.

The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract, at which time the performance obligation is deemed to be completed. The Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement and bears risk of loss while the inventory is in-transit to the commercial partner. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to a customer.

b) License Fees

The Company enters into licensing and development agreements, which may include multiple revenue generating activities, including milestones payments, licensing fees, product sales and services. The Company analyzes each element of its licensing and development agreements in accordance with ASC 606 to determine appropriate revenue recognition. The terms of the license agreement may include payment to the Company of licensing fees, non-refundable upfront license fees, milestone payments if specified objectives are achieved, and/or royalties on product sales.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

The Company recognizes revenue from non-refundable upfront payments at a point in time, typically upon fulfilling the delivery of the associated intellectual property to the customer. For those milestone payments which are contingent on the occurrence of particular future events (for example, payments due upon a product receiving FDA approval), the Company determined that these need to be considered for inclusion in the calculation of total consideration from the contract as a component of variable consideration using the most-likely amount method. As such, the Company assesses each milestone to determine the probability and substance behind achieving each milestone. Given the inherent uncertainty of the occurrence of future events, the Company will recognize revenue from the milestone when there is not a high probability of a reversal of revenue, which typically occurs near or upon achievement of the event.

They were working OT at old facility as of last cc. New facility will create some excellent operational and financial efficiencies.

Just a quick note - the $5.76M would be top line rev, not bottom line. Looking forward to seeing COGS and flow through to profit + additional shifts be added with this new demand. 

Also, any production last few days of Q2 will likely just be shipped this week and recorded in Q3 rev.

Whats your thoughts on a Trad IRA if we have a buy out this year ???

I think Elite is going to capture a large market share of Vyvanse just as it did Adderall because these are Elite's most important products. Kirkov can explain to customers that Elite's a small company that is laser focused on getting quota and converting it to product as fast as possible to make sure customers orders are delivered on time and with the full quantity. Most other generic drug companies have billions in revenue and Adderall and Vyvanse are just two more drugs in a very large product line. These drugs are not likely to be the most profitable products for large generic companies, probably not even in the top 10 profitable product, and thus do not warrant extra attention and care like Elite will give them. Any company already getting Adderall from Elite is going to be thrilled to order Vyvanse from them because of their reliability and quality. Our market penetration for Vyvanse could go very quickly.

I can tell you exactly what happened. On October 22, the largest amount of shares traded and eltp stock got wallop, and It has never recovered from that date, every single good news that came out was followed by a downward price reaction and it hasn't stop. I believe Zacks had a play in this situation, by creating a strong buy rating and touting how great this company can be, it was actually shorted and sold into the 70"s range. My e-mail is cluttered with Zacks wanting my business. Creating a hostile environment makes the investor jittery thus looking for some advice which is where Zacks comes in. A beautiful setup I must say. So now eltp has to prove its worth in order for the stock to hit another 52 week high.

As always thanks

If they worked 2 shifts, for 5 days at the end of the year, that translates to 576,000 bottles of Vyvanse.

Even at 10 bucks a bottle, that is 5.76 Million more to the botton line.

Haven't seen any open positions for 2nd shift, which is a bit surprising. Could be using a 3rd party.

Snup, Basically, Elite was letting Lannett sell the IR and ER generic Adderall, till Lannet filed and go approval to sell their own
IR and ER, and Elite had to go out and sell on their own, with their own label.
Enter Kirko stage left, he started selling every pill Elite could make and saved the company,

It looks like a million shares traded already? Tight rAnge, hoping it's not a typo on volume this far?

What do you think an additional $400 million in revenue from Vyvanse do for the SP and the BuyOut price ?

Watch and learn some more .

Youve been educated since 2 cents

GLTY

There is no way anyone can deny that the revenues for the quarter that ends tomorrow is going to be anything but record breaking. With just the launch of Norco the revs were going to go up a healthy amount, but with the launch of Vyvanse the increase will be much higher even if it was a small shipment. Maybe even today Elite employees could be cranking out the Vyvanse for shipment before COB tomorrow. Elite is a very safe investment compared to the general markets at today's price level.

one million shares by 10:30 AM - Not bad

You are talking about an IRA conversion to a Roth. I was addressing the situation of investing in a Roth in Jan 2025 because expected MAGI was going to be under the limit only to have the MAGI blow up when Elite is sold and non-Roth Elite investments get converted to cash in a normal brokerage account. We are talking about apples and oranges.

Most people invest in 401ks not IRAs for their retirement. If they occasionally invested in an IRA they would have been smart to choose a Roth and not a conventional IRA. So I think you are unusual in having a pile of money in a traditional IRA through which to do a backdoor conversion.

I am going to repeat though that I believe the chance of Elite getting sold and that sale finalizing in 2025 is very very low.

Did u buy some today? Welcome aboard!

The Vyvanse flop continues.
I read (on this MB) this was a "needle mover", Billions...lol
Can some one explain what happened.
Why is this moving in the wrong direction ??

If you are older than 59.5 years old and you did an IRA to ROTH conversion this year, you will have to pay taxes on the conversion by January 15th 2025. If you want to push that date to April 15th 2025, you need to make sure you have paid 110% of your taxes amount for 2023 - both Federal and State tax. That makes you "grandfathered" and you can pay the big amount by April 15 2025. It is also better to pay that big tax on Elite gains using non roth IRA funds as they will grow more in 2025 and 2026.

Hi Kayak, If they do not pull out their money, it is unrealized gains and they do not have to worry in case of a buyout.

Good morning Sharkey, doing a little catch-up research today , could u briefly tell me what happened to lannet? Were they selling Adderall? Thanks

I have owned too many companies w weak and poor leaders. They were much more overpriced as they did nothing to enhance shareholder value. Musk and Naz may be overpayed, but in today’s world, they have enhanced my wealth as I believe in both of their leadership/vision skills. I’m elated I own both companies, mostly due to those 2 people.

Dianne updated the product page. Good to see.

Just my opinion again

How does Nasrat not lend elite the money to buy out sungen. It wasn’t because he was worried about losing money on the loan. If that was the case , he would have never paid sungen. It was , again, my opinion, just greed. Elite could have so much more revenue and profit now instead of so much of going to MIKAH ( HAKIM). Just so so so wrong in my opinion. What really pisses me off is his arrogance when asked about it. Screw you people for questioning me and my desire to make even more money.

Also, when will there be an accounting of all the shares he has and what were they for. How much did elite sell on the stuff that he sold elite ?

Last; question - do CEO’s of small companies make a million per year with a car and housing allowance. How did the board come up with this salary. Who did they benchmark against

All just my opinion.

Just for reference

https://www.findacode.com/ndc/labelers/Elite_Laboratories%2C_Inc.--64850

I hope prk8r3 answers. I’d like to know if AmeriSource Bergen Stocks Elite Vyvanse yet. Cardinal does not show it yet.

I’m beginning to wonder ?
Thx

Free PMs till the 1st.

Able to see Vyvanse availability yet? Figured that might take a few weeks.

Hi HGIS. I believe the poster was asking what would happen if they contributed to a Roth but later had income that meant they shouldn't have contributed to a Roth. There are income limits that if one is above prevents contribution to a Roth. One of those things that contribute to the income is capital gains. So sure if you contribute to a Roth when you were legally allowed to you don't pay tax on those gains. But again some posters are worried that a buyout that results in a cash payout in 2025 will push up the income unexpectedly very high.

Hi kayak. If you do not pull out your gains from your Roth IRA you would not have to pay taxes. (After 59.5 years old). 5 year rule.

Everything is a big word. It does means someone doesn't get the extra 10% penalty. But they would still have to pay short-term capital gain rates on the profits made in the investment, pull the money invested in 2025 and the money made in 2025 out of the Roth IRA before Apr 15 2026, and submit the necessary tax forms showing how the situation was corrected. But again, I think a buyout being finalized in 2026 is a long shot. But the stock price could jump up so high someone wants to sell. Bottom line is an additional $5k to $7k investment in a Roth worth the hassle?

Are you older than 59.5? It changes everything.

Another possible option is do a traditional IRA for 2025 and don’t touch it till your retired and not earning any thing. Then you maybe able to take out $14,600 single $29,,200 married a year without any tax ?


Standard Deductions

For the tax year 2025, single taxpayers and married individuals filing separately will see their standard deduction - the amount of income that is not taxable - increase to $14,600 for 2024, up by $750 from 2023.

Married couples filing jointly will benefit from a standard deduction of $29,200, a $1,500 increase from 2024. Heads of households will have a standard deduction set at $22,500 for 2025, reflecting a $600 rise compared to the amount for tax year 2024.

I sure will thank you

If you earn to much to make a ROTH contribution you can still make a Traditional IRA contribution and immediately roll it over into your ROTH account. You just don't get the tax defferred benefit of the money for 2025. However, you still made a ROTH contribution that will now grow tax free. 

Thank you NASDAQ2020 l sent a private message but not sure it went through will try again on free Friday’s HAPPY NEW YEAR TO ALL🇺🇸

Kayak’s post also applies.

To best of my knowledge (which may not be right). If there is a buyout in 2025 I may not be eligible to do a Roth IRA 2025 because 1/3 of my ELTP is in a trading account. Let’s say I make a million dollars in that account that maybe too much to qualify to do a 2025/ Roth. I was going to do my 2025 Roth in Jan 2025. I decided to hold off , if no sale in 2025 I can do my Roth 2025 between Jan 2026 and April 2026.
What I need to know Kenny is if All your ELTP in a Roth now. If all is in Roth now you can probably do your 2025 Roth in Jan 2025 or anytime during the year. Let me know what % of your shares are in a Roth now and how much not in Roth.
You still can pm during Holiday if you don’t want to share with board.

Roth IRA income limits for 2025
The Roth IRA income limit to make a full contribution in 2025 is less than $150,000 for single filers, and less than $236,000 for those filing jointly. If you’re a single filer, you’re eligible to contribute a portion of the full amount if your MAGI is $150,000 or more, but less than $165,000. For those married filing jointly, the income range to contribute a portion of the full amount is $236,000 or more, but less than $246,000. If you’re a single filer and your MAGI is $165,000 or more, or if you’re a joint filer and your MAGI is $246,000 or more, you’re ineligible to contribute to a Roth IRA. Still, you can make contributions to a traditional IRA.

If you make lot of money out of Roth account during 2025 that may take you over the maximum you can make to qualify to do a Roth of $236,000 if filing jointly.

Thank you k w, you can tell lm a CPA hire candidate, but a firm believer in ELTP$$$$$ since 2011 and some Roth contributer, l still have some flexibility but love your very informative explanation thank you!!!